Cognition endpoints for Parkinson's disease: A roadmap for developing patient-focused assessment tools to accelerate drug development

Journal of Parkinson’s Disease · Published 2026-09-21 · Journal article · DOI 10.1177/1877718x261483866

Free full text

Authors (10)

Chris J Edgar, Kathleen L Poston, Cheryl D Coon, Fraser D Bocell, Tien Dam, Yuge Xiao, Catherine M Kopil, Tanya Simuni, Daniel Weintraub, Thomas Morel

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Edgar, C., Poston, K., Coon, C., et al. (2026). Cognition endpoints for Parkinson's disease: A roadmap for developing patient-focused assessment tools to accelerate drug development. Journal of Parkinson’s Disease. https://doi.org/10.1177/1877718x261483866

Related articles

• Integrating a biopsychosocial perspective: WHODAS 2.0 enhances functioning assessment in Parkinson's disease · Journal of Parkinson’s Disease · 2026 · Same journal
• A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson's disease symptoms · Journal of Parkinson’s Disease · 2025 · Same journal
• A review of FDG-PET biomarker analysis methods in Parkinson's disease · Journal of Parkinson’s Disease · 2026 · Same journal
• Effects of deep brain stimulation on functional autonomy and quality of life in Parkinson's disease: A systematic review and meta-analysis · Journal of Parkinson’s Disease · 2026 · Same journal
• Association between age at Parkinson's disease onset and divorce: An exploratory analysis from the fox insight cohort · Journal of Parkinson’s Disease · 2026 · Same journal
• Continuous apomorphine infusion modulates cortical hyperexcitability and abnormal plasticity in Parkinson's disease · Journal of Parkinson’s Disease · 2026 · Same journal
• Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape · Journal of Parkinson’s Disease · 2026 · Same journal
• Gut microbiome dysbiosis, short-chain fatty acid depletion and implications for neuroinflammation in atypical parkinsonian syndromes – a systematic review of patient cohorts · Journal of Parkinson’s Disease · 2026 · Same journal
• Aligning incentives for open science in biomedical research: Navigating funder and institutional perspectives · Journal of Parkinson’s Disease · 2025 · Same journal
• Prevalence and related factors of blood pressure regulation abnormalities in Parkinson's disease: Orthostatic hypotension and supine hypertension · Journal of Parkinson’s Disease · 2025 · Same journal